{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T20:25:05Z","timestamp":1780431905265,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,4,6]],"date-time":"2011-04-06T00:00:00Z","timestamp":1302048000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genet Vaccines Ther"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1479-0556-9-7","type":"journal-article","created":{"date-parts":[[2011,4,7]],"date-time":"2011-04-07T06:18:25Z","timestamp":1302157105000},"source":"Crossref","is-referenced-by-count":16,"title":["In-vitro model systems to study Hepatitis C Virus"],"prefix":"10.1186","volume":"9","author":[{"given":"Usman Ali","family":"Ashfaq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaheen N","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zafar","family":"Nawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheikh","family":"Riazuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,4,6]]},"reference":[{"key":"90_CR1","first-page":"4","volume":"41","author":"NSJK Raja","year":"2008","unstructured":"Raja NSJK, Janjua KA: Epidemiology of hepatitis C virus infection in Pakistan. J Microbiol Immunol Infect. J Microbiol Immunol Infect. 2008, 41: 4-8.","journal-title":"J Microbiol Immunol Infect"},{"key":"90_CR2","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/S0168-8278(01)00179-9","volume":"35","author":"M Berenguer","year":"2001","unstructured":"Berenguer M, Lopez-Labrador FX, Wright TL: Hepatitis C and liver transplantation. J Hepatol. 2001, 35: 666-678. 10.1016\/S0168-8278(01)00179-9.","journal-title":"J Hepatol"},{"key":"90_CR3","first-page":"838","volume":"5","author":"PL Beaulieu","year":"2004","unstructured":"Beaulieu PL, Tsantrizos YS: Inhibitors of the HCV NS5B polymerase: new hope for the treatment of hepatitis C infections. Curr Opin Investig Drugs. 2004, 5: 838-850.","journal-title":"Curr Opin Investig Drugs"},{"key":"90_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0166-3542(03)00028-7","volume":"58","author":"R De Francesco","year":"2003","unstructured":"De Francesco R, Tomei L, Altamura S, Summa V, Migliaccio G: Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase. Antiviral Res. 2003, 58: 1-16. 10.1016\/S0166-3542(03)00028-7.","journal-title":"Antiviral Res"},{"key":"90_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1055\/s-2007-1007262","volume":"15","author":"J Bukh","year":"1995","unstructured":"Bukh J, Miller RH, Purcell RH: Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis. 1995, 15: 41-63. 10.1055\/s-2007-1007262.","journal-title":"Semin Liver Dis"},{"issue":"Pt 11","key":"90_CR6","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1099\/0022-1317-74-11-2391","volume":"74","author":"P Simmonds","year":"1993","unstructured":"Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, Yap PL, Kolberg J, Urdea MS: Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol. 1993, 74 (Pt 11): 2391-2399. 10.1099\/0022-1317-74-11-2391.","journal-title":"J Gen Virol"},{"key":"90_CR7","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1128\/JCM.32.4.884-892.1994","volume":"32","author":"F McOmish","year":"1994","unstructured":"McOmish F, Yap PL, Dow BC: Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol. 1994, 32: 884-892.","journal-title":"J Clin Microbiol"},{"key":"90_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.7326\/0003-4819-122-3-199502010-00001","volume":"122","author":"JB Nousbaum","year":"1995","unstructured":"Nousbaum JB, Pol S, Nalpas B, Group atCS: Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med. 1995, 122: 161-168.","journal-title":"Ann Intern Med"},{"key":"90_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1471-2334-8-69","volume":"8","author":"M Idrees","year":"2008","unstructured":"Idrees M, Riazuddin S: Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. BMC Infect Dis. 2008, 8: 69-10.1186\/1471-2334-8-69.","journal-title":"BMC Infect Dis"},{"key":"90_CR10","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1001\/jama.289.18.2413","volume":"289","author":"SL Flamm","year":"2003","unstructured":"Flamm SL: Chronic hepatitis C virus infection. Jama. 2003, 289: 2413-2417. 10.1001\/jama.289.18.2413.","journal-title":"Jama"},{"key":"90_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11894-002-0034-y","volume":"4","author":"M Cornberg","year":"2002","unstructured":"Cornberg M, Wedemeyer H, Manns MP: Treatment of chronic hepatitis C with PEGylated interferon and ribavirin. Curr Gastroenterol Rep. 2002, 4: 23-30. 10.1007\/s11894-002-0034-y.","journal-title":"Curr Gastroenterol Rep"},{"key":"90_CR12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1046\/j.1365-2125.1998.00836.x","volume":"46","author":"S Khakoo","year":"1998","unstructured":"Khakoo S, Glue P, Grellier L, Wells B, Bell A, Dash C, Murray-Lyon I, Lypnyj D, Flannery B, Walters K, Dusheiko GM: Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions. Br J Clin Pharmacol. 1998, 46: 563-570. 10.1046\/j.1365-2125.1998.00836.x.","journal-title":"Br J Clin Pharmacol"},{"key":"90_CR13","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/S0016-5085(03)00394-9","volume":"124","author":"MW Russo","year":"2003","unstructured":"Russo MW, Fried MW: Side effects of therapy for chronic hepatitis C. Gastroenterology. 2003, 124: 1711-1719. 10.1016\/S0016-5085(03)00394-9.","journal-title":"Gastroenterology"},{"key":"90_CR14","first-page":"1328","volume":"26","author":"S Iacovacci","year":"1997","unstructured":"Iacovacci S, Manzin A, Barca S, Sargiacomo M, Serafino A, Valli MB, Macioce G, Hassan HJ, Ponzetto A, Clementi M, et al: Molecular characterization and dynamics of hepatitis C virus replication in human fetal hepatocytes infected in vitro. Hepatology. 1997, 26: 1328-1337.","journal-title":"Hepatology"},{"key":"90_CR15","doi-asserted-by":"publisher","first-page":"478","DOI":"10.2353\/ajpath.2007.060789","volume":"170","author":"CA Lazaro","year":"2007","unstructured":"Lazaro CA, Chang M, Tang W, Campbell J, Sullivan DG, Gretch DR, Corey L, Coombs RW, Fausto N: Hepatitis C virus replication in transfected and serum-infected cultured human fetal hepatocytes. Am J Pathol. 2007, 170: 478-489. 10.2353\/ajpath.2007.060789.","journal-title":"Am J Pathol"},{"key":"90_CR16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3748\/wjg.v7.i5.685","volume":"7","author":"ZQ Song","year":"2001","unstructured":"Song ZQ, Hao F, Min F, Ma QY, Liu GD: Hepatitis C virus infection of human hepatoma cell line 7721 in vitro. World J Gastroenterol. 2001, 7: 685-689.","journal-title":"World J Gastroenterol"},{"key":"90_CR17","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/j.1349-7006.1996.tb02101.x","volume":"87","author":"N Kato","year":"1996","unstructured":"Kato N, Ikeda M, Mizutani T, Sugiyama K, Noguchi M, Hirohashi S, Shimotohno K: Replication of hepatitis C virus in cultured non-neoplastic human hepatocytes. Jpn J Cancer Res. 1996, 87: 787-792.","journal-title":"Jpn J Cancer Res"},{"issue":"Pt 10","key":"90_CR18","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1099\/0022-1317-78-10-2467","volume":"78","author":"S Seipp","year":"1997","unstructured":"Seipp S, Mueller HM, Pfaff E, Stremmel W, Theilmann L, Goeser T: Establishment of persistent hepatitis C virus infection and replication in vitro. J Gen Virol. 1997, 78 (Pt 10): 2467-2476.","journal-title":"J Gen Virol"},{"key":"90_CR19","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.1128\/JVI.70.10.7219-7223.1996","volume":"70","author":"T Mizutani","year":"1996","unstructured":"Mizutani T, Kato N, Saito S, Ikeda M, Sugiyama K, Shimotohno K: Characterization of hepatitis C virus replication in cloned cells obtained from a human T-cell leukemia virus type 1-infected cell line, MT-2. J Virol. 1996, 70: 7219-7223.","journal-title":"J Virol"},{"issue":"Pt 6","key":"90_CR20","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1099\/0022-1317-79-6-1383","volume":"79","author":"YK Shimizu","year":"1998","unstructured":"Shimizu YK, Igarashi H, Kiyohara T, Shapiro M, Wong DC, Purcell RH, Yoshikura H: Infection of a chimpanzee with hepatitis C virus grown in cell culture. J Gen Virol. 1998, 79 (Pt 6): 1383-1386.","journal-title":"J Gen Virol"},{"issue":"Pt 5","key":"90_CR21","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1099\/0022-1317-77-5-1043","volume":"77","author":"T Ito","year":"1996","unstructured":"Ito T, Mukaigawa J, Zuo J, Hirabayashi Y, Mitamura K, Yasui K: Cultivation of hepatitis C virus in primary hepatocyte culture from patients with chronic hepatitis C results in release of high titre infectious virus. J Gen Virol. 1996, 77 (Pt 5): 1043-1054. 10.1099\/0022-1317-77-5-1043.","journal-title":"J Gen Virol"},{"key":"90_CR22","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1126\/science.290.5498.1972","volume":"290","author":"KJ Blight","year":"2000","unstructured":"Blight KJ, Kolykhalov AA, Rice CM: Efficient initiation of HCV RNA replication in cell culture. Science. 2000, 290: 1972-1974. 10.1126\/science.290.5498.1972.","journal-title":"Science"},{"key":"90_CR23","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1126\/science.285.5424.110","volume":"285","author":"V Lohmann","year":"1999","unstructured":"Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R: Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science. 1999, 285: 110-113. 10.1126\/science.285.5424.110.","journal-title":"Science"},{"key":"90_CR24","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1128\/JVI.77.5.3007-3019.2003","volume":"77","author":"V Lohmann","year":"2003","unstructured":"Lohmann V, Hoffmann S, Herian U, Penin F, Bartenschlager R: Viral and cellular determinants of hepatitis C virus RNA replication in cell culture. J Virol. 2003, 77: 3007-3019. 10.1128\/JVI.77.5.3007-3019.2003.","journal-title":"J Virol"},{"key":"90_CR25","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/nrd942","volume":"1","author":"R Bartenschlager","year":"2002","unstructured":"Bartenschlager R: Hepatitis C virus replicons: potential role for drug development. Nat Rev Drug Discov. 2002, 1: 911-916. 10.1038\/nrd942.","journal-title":"Nat Rev Drug Discov"},{"key":"90_CR26","doi-asserted-by":"publisher","first-page":"14416","DOI":"10.1073\/pnas.212532699","volume":"99","author":"J Bukh","year":"2002","unstructured":"Bukh J, Pietschmann T, Lohmann V, Krieger N, Faulk K, Engle RE, Govindarajan S, Shapiro M, St Claire M, Bartenschlager R: Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees. Proc Natl Acad Sci USA. 2002, 99: 14416-14421. 10.1073\/pnas.212532699.","journal-title":"Proc Natl Acad Sci USA"},{"key":"90_CR27","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1128\/JVI.75.3.1252-1264.2001","volume":"75","author":"T Pietschmann","year":"2001","unstructured":"Pietschmann T, Lohmann V, Rutter G, Kurpanek K, Bartenschlager R: Characterization of cell lines carrying self-replicating hepatitis C virus RNAs. J Virol. 2001, 75: 1252-1264. 10.1128\/JVI.75.3.1252-1264.2001.","journal-title":"J Virol"},{"key":"90_CR28","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1128\/JVI.77.5.3181-3190.2003","volume":"77","author":"KJ Blight","year":"2003","unstructured":"Blight KJ, McKeating JA, Marcotrigiano J, Rice CM: Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture. J Virol. 2003, 77: 3181-3190. 10.1128\/JVI.77.5.3181-3190.2003.","journal-title":"J Virol"},{"key":"90_CR29","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nm1268","volume":"11","author":"T Wakita","year":"2005","unstructured":"Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, Murthy K, Habermann A, Krausslich HG, Mizokami M, et al: Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med. 2005, 11: 791-796. 10.1038\/nm1268.","journal-title":"Nat Med"},{"key":"90_CR30","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1126\/science.1114016","volume":"309","author":"BD Lindenbach","year":"2005","unstructured":"Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC, Maruyama T, Hynes RO, Burton DR, McKeating JA, Rice CM: Complete replication of hepatitis C virus in cell culture. Science. 2005, 309: 623-626. 10.1126\/science.1114016.","journal-title":"Science"},{"key":"90_CR31","doi-asserted-by":"publisher","first-page":"9294","DOI":"10.1073\/pnas.0503596102","volume":"102","author":"J Zhong","year":"2005","unstructured":"Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, Wieland SF, Uprichard SL, Wakita T, Chisari FV: Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA. 2005, 102: 9294-9299. 10.1073\/pnas.0503596102.","journal-title":"Proc Natl Acad Sci USA"},{"key":"90_CR32","doi-asserted-by":"publisher","first-page":"13963","DOI":"10.1128\/JVI.79.22.13963-13973.2005","volume":"79","author":"Z Cai","year":"2005","unstructured":"Cai Z, Zhang C, Chang KS, Jiang J, Ahn BC, Wakita T, Liang TJ, Luo G: Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells. J Virol. 2005, 79: 13963-13973. 10.1128\/JVI.79.22.13963-13973.2005.","journal-title":"J Virol"},{"key":"90_CR33","doi-asserted-by":"publisher","first-page":"7271","DOI":"10.1073\/pnas.0832180100","volume":"100","author":"M Hsu","year":"2003","unstructured":"Hsu M, Zhang J, Flint M, Logvinoff C, Cheng-Mayer C, Rice CM, McKeating JA: Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc Natl Acad Sci USA. 2003, 100: 7271-7276. 10.1073\/pnas.0832180100.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Genetic Vaccines and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-0556-9-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1479-0556-9-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-0556-9-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T01:17:34Z","timestamp":1592443054000},"score":1,"resource":{"primary":{"URL":"https:\/\/gvt-journal.biomedcentral.com\/articles\/10.1186\/1479-0556-9-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,6]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["90"],"URL":"https:\/\/doi.org\/10.1186\/1479-0556-9-7","relation":{},"ISSN":["1479-0556"],"issn-type":[{"value":"1479-0556","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,6]]},"article-number":"7"}}